NO176665C - Fremgangsmåte for fremstilling av ikke-glykosylert IL-6 og vektor for utskillelse derav - Google Patents

Fremgangsmåte for fremstilling av ikke-glykosylert IL-6 og vektor for utskillelse derav

Info

Publication number
NO176665C
NO176665C NO880929A NO880929A NO176665C NO 176665 C NO176665 C NO 176665C NO 880929 A NO880929 A NO 880929A NO 880929 A NO880929 A NO 880929A NO 176665 C NO176665 C NO 176665C
Authority
NO
Norway
Prior art keywords
glycosylated
secretion
vector
preparation
hematopoietins
Prior art date
Application number
NO880929A
Other languages
English (en)
Norwegian (no)
Other versions
NO880929L (no
NO176665B (no
NO880929D0 (no
Inventor
Steven C Clark
Gordon G Wong
Paul Schendel
John Mccoy
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27367237&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO176665(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genetics Inst filed Critical Genetics Inst
Publication of NO880929L publication Critical patent/NO880929L/no
Publication of NO880929D0 publication Critical patent/NO880929D0/no
Publication of NO176665B publication Critical patent/NO176665B/no
Publication of NO176665C publication Critical patent/NO176665C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
NO880929A 1986-07-08 1988-03-02 Fremgangsmåte for fremstilling av ikke-glykosylert IL-6 og vektor for utskillelse derav NO176665C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US88320786A 1986-07-08 1986-07-08
US88590586A 1986-07-15 1986-07-15
US4795787A 1987-05-08 1987-05-08
PCT/US1987/001611 WO1988000206A1 (fr) 1986-07-08 1987-07-07 Production et utilisation d'il-6

Publications (4)

Publication Number Publication Date
NO880929L NO880929L (no) 1988-03-02
NO880929D0 NO880929D0 (no) 1988-03-02
NO176665B NO176665B (no) 1995-01-30
NO176665C true NO176665C (no) 1995-05-10

Family

ID=27367237

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880929A NO176665C (no) 1986-07-08 1988-03-02 Fremgangsmåte for fremstilling av ikke-glykosylert IL-6 og vektor for utskillelse derav

Country Status (18)

Country Link
EP (2) EP0574955B1 (fr)
JP (1) JP2664698B2 (fr)
KR (1) KR960013601B1 (fr)
AT (2) ATE124959T1 (fr)
AU (1) AU615630B2 (fr)
CA (1) CA1341355C (fr)
DE (2) DE3751406T2 (fr)
DK (1) DK173279B1 (fr)
ES (1) ES2006776A6 (fr)
GR (1) GR871027B (fr)
IE (1) IE67035B1 (fr)
IL (1) IL83137A (fr)
MY (1) MY102865A (fr)
NO (1) NO176665C (fr)
PL (1) PL159182B1 (fr)
PT (1) PT85285B (fr)
SK (1) SK515087A3 (fr)
WO (1) WO1988000206A1 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554513A (en) * 1979-11-21 1996-09-10 Yeda Research & Development Co. Ltd. Production of recombinant human interferon-beta2
US5510472A (en) * 1979-11-21 1996-04-23 Yeda Research And Development Co. Ltd. Production of recombinant human interferon-beta2
CA1341369C (fr) * 1985-10-14 2002-06-18 Michel Revel Interferons .beta.2a et .beta.2b humains; vecteurs contenant des genes codant pour lesdits interferons, lignees de cellules les produisant et utilisation desdits interferons a titre de medicament
JP2648860B2 (ja) * 1986-05-08 1997-09-03 イエダ リサーチ アンド デベロップメント コンパニー リミテッド ヒトインターフエロン−β２Ａ及びヒトインターフエロン−β２Ｂ、該インターフエロンをコードする遺伝子を含むベクター、該インターフエロンを産生するセルライン及び該インターフエロンの医薬品としての用途
JP2676336B2 (ja) * 1986-08-06 1997-11-12 忠三 岸本 ヒトｂ細胞分化因子の遺伝子
DE3750106T3 (de) * 1986-08-06 1999-04-22 Ajinomoto Co., Inc., Tokio/Tokyo Rekombinanter B-Zell-Differenzierungsfaktor.
JPS6356291A (ja) * 1986-08-27 1988-03-10 Chuzo Kishimoto リコンビナントｂｃｄｆ
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
CA1341588C (fr) * 1988-01-26 2009-01-06 Michel Revel Ifn-beta2/i1-6, humain, sa purification et ses utilisations
IL85204A0 (en) * 1988-01-26 1988-07-31 Yeda Res & Dev Recombinant human interferon beta2,its preparation and pharmaceutical compositions comprising it
HUT52962A (en) * 1988-03-04 1990-09-28 Sandoz Ag Process for production of medical compositions eliminating bone-absorption and promoting forming of bones
JPH022353A (ja) * 1988-03-10 1990-01-08 Tosoh Corp ヒトｂ細胞分化因子の製造法
JPH022354A (ja) * 1988-03-31 1990-01-08 Tosoh Corp ヒトｂ細胞分化因子の製造法
GB2217327B (en) * 1988-04-12 1992-01-29 British Bio Technology Synthetic interleukin-6 gene
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
US5646015A (en) * 1988-08-31 1997-07-08 Astra Ab Excretion of heterologous proteins from E. coli
US5271931A (en) * 1988-09-14 1993-12-21 The Scripps Research Institute Methods for increasing C1 inhibitor concentrations using interferon-gamma and/or interleukin-6
JPH0372429A (ja) * 1988-10-07 1991-03-27 Chugai Pharmaceut Co Ltd 血小板減少症の治療剤
US5811523A (en) 1988-11-10 1998-09-22 Trinchieri; Giorgio Antibodies to natural killer stimulatory factor
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤
JPH0331215A (ja) * 1989-06-27 1991-02-12 Ajinomoto Co Inc 制癌療法支持剤
DE3939706C1 (fr) * 1989-12-01 1991-03-21 Centre Regional De Transfusion Sanguine, Besancon, Fr
JPH04218000A (ja) * 1990-02-13 1992-08-07 Kirin Amgen Inc 修飾ポリペプチド
WO1992004041A1 (fr) * 1990-08-31 1992-03-19 Santen Pharmaceutical Co., Ltd. Remede pour traiter les atteintes a la cornee
ATE210150T1 (de) * 1991-04-18 2001-12-15 Toray Industries Verfahren zur herstellung von interleukin-6 zusammensetzungen
US5641868A (en) * 1991-04-18 1997-06-24 Toray Industries, Inc. Interlekin-6 compositions, and a production process thereof
ZA924674B (en) * 1991-07-02 1993-04-28 Imclone Systems Inc Cysteine depleted il-6 mutein
US5338833A (en) * 1992-07-23 1994-08-16 The University Of North Carolina At Chapel Hill Carboxy terminal IL-6 muteins
US5338834A (en) * 1993-01-26 1994-08-16 Allelix Biopharmaceuticals Inc. Ultrapure human interleukin-6
WO1994028919A1 (fr) * 1993-06-08 1994-12-22 Ajinomoto Co., Inc. Accelerateur de la proliferation des cellules hematopietiques
US5599536A (en) * 1993-12-13 1997-02-04 Sandoz Ltd. Method for suppressing the acute phase response in a patient receiving IL-6 therapy
US5578301A (en) * 1993-12-14 1996-11-26 Sandoz Ltd. Method for using GM-CSF to reduce the acute phase response in a patient being administered IL-6 therapy
US5641657A (en) * 1994-05-19 1997-06-24 Human Genome Sciences, Inc. DNA encoding an interleukin-6 splice variant
EP0721780A3 (fr) * 1994-12-16 1997-12-17 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Agent pour activer la production de plaquettes et/ou de leucocytes
WO1998003657A1 (fr) 1996-07-19 1998-01-29 Dade Behring Marburg Gmbh Interleukine-6 virale
SE9702401D0 (sv) 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
US7479540B1 (en) 2003-12-22 2009-01-20 Chandan Prasad Adipomodulin and related molecules and methods
EP1856147A4 (fr) * 2005-02-15 2008-07-02 Apollo Life Sciences Ltd Molécule et molécules chimères de celle-ci
ES2302402B1 (es) * 2005-06-16 2009-05-08 Proyecto De Biomedicina Cima, S.L. Uso de una citoquina de la familia de interleuquina-6 en la preparacion de una composicion para administracion combinada con interferon-alfa.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US4675285A (en) * 1984-09-19 1987-06-23 Genetics Institute, Inc. Method for identification and isolation of DNA encoding a desired protein
CA1341369C (fr) * 1985-10-14 2002-06-18 Michel Revel Interferons .beta.2a et .beta.2b humains; vecteurs contenant des genes codant pour lesdits interferons, lignees de cellules les produisant et utilisation desdits interferons a titre de medicament
DE3750106T3 (de) * 1986-08-06 1999-04-22 Ajinomoto Co., Inc., Tokio/Tokyo Rekombinanter B-Zell-Differenzierungsfaktor.

Also Published As

Publication number Publication date
WO1988000206A1 (fr) 1988-01-14
ATE124959T1 (de) 1995-07-15
DK173279B1 (da) 2000-06-05
DK121788D0 (da) 1988-03-07
EP0574955B1 (fr) 1996-10-09
KR960013601B1 (ko) 1996-10-09
GR871027B (en) 1987-11-02
ES2006776A6 (es) 1989-05-16
DE3751922D1 (de) 1996-11-14
CA1341355C (fr) 2002-04-09
DK121788A (da) 1988-03-07
DE3751406T2 (de) 1995-12-21
KR880701736A (ko) 1988-11-04
PL266680A1 (en) 1988-07-07
AU7696287A (en) 1988-01-29
EP0316319A1 (fr) 1989-05-24
PL159182B1 (pl) 1992-11-30
NO880929L (no) 1988-03-02
JP2664698B2 (ja) 1997-10-15
PT85285B (pt) 1990-03-30
IE67035B1 (en) 1996-02-21
IE871726L (en) 1988-01-08
SK279144B6 (sk) 1998-07-08
SK515087A3 (en) 1998-07-08
PT85285A (en) 1987-08-01
MY102865A (en) 1993-03-31
DE3751406D1 (de) 1995-08-17
EP0316319B1 (fr) 1995-07-12
NO176665B (no) 1995-01-30
DE3751922T2 (de) 1997-04-03
EP0316319A4 (fr) 1989-08-09
AU615630B2 (en) 1991-10-10
NO880929D0 (no) 1988-03-02
EP0574955A1 (fr) 1993-12-22
JPH01503354A (ja) 1989-11-16
IL83137A (en) 1995-05-26
ATE143811T1 (de) 1996-10-15

Similar Documents

Publication Publication Date Title
NO176665C (no) Fremgangsmåte for fremstilling av ikke-glykosylert IL-6 og vektor for utskillelse derav
PH25120A (en) Replicable expression vehicle and process of preparation thereof
ES2007341A6 (es) Un procedimiento para producir m-csf
ZA841597B (en) Human nerve growth factor by recombinant technology
AU2881389A (en) Human ifn-beta 2/il-6, its purification and use
BG60238B1 (bg) Човешки тумор- некротизиращ фактор
PT86205A (en) Process for the preparation of 3-]omega-(3,5-di-t-butil-4-hydroxyphenyl)-alkanoyl"pyrroles and their de-oxy analogs useful in therapy
DE3572441D1 (en) Use of interferon gamma (ifn-gamma) for the production of preparations for treating rheumatic diseases
IL82654A0 (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ATE92333T1 (de) Arzneimittel zur intralesionsbehandlung von schuppenartigem zellkarzinomen mit rekombinantem human-alpha-interferon.
Watkins et al. Further characterization of A T-cell growth factor from the frog, Xenopus
EP0278715A3 (fr) Utilisation d'interféron gamma humain pour le traitement du carcinome de cellules basales
HU900202D0 (en) Process for manufacturing of pharmaceutical compositions comprising gamma-interferon suitable to treatment of ovarion cancer